Bensler, LLC Zoetis Inc. Transaction History

Bensler, LLC

$793 Billion
Q3 2024

A detailed history of Bensler, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Bensler, LLC holds 16,873 shares of ZTS stock, worth $2.79 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

16,873

Previous 17,217 2.0%

Holding current value

$2.79 Million

Previous $2.98 Billion 10.45%

% of portfolio

0.42%

Previous 0.4%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$172.58 - $196.48 $59,367 - $67,589	-344 Reduced 2.0%	16,873 $3.3 Billion
Q2 2024 Jul 26, 2024	SELL	$145.54 - $178.83 $52,248 - $64,199	-359 Reduced 2.04%	17,217 $2.98 Billion
Q1 2024 Apr 30, 2024	SELL	$165.67 - $199.94 $49,038 - $59,182	-296 Reduced 1.66%	17,576 $2.97 Billion
Q4 2023 Jan 22, 2024	SELL	$151.44 - $200.09 $121,909 - $161,072	-805 Reduced 4.31%	17,872 $3.53 Billion
Q3 2023 Oct 25, 2023	BUY	$167.14 - $192.77 $43,289 - $49,927	259 Added 1.41%	18,677 $3.25 Billion
Q2 2023 Jul 20, 2023	SELL	$160.94 - $186.23 $73,549 - $85,107	-457 Reduced 2.42%	18,418 $3.17 Billion
Q1 2023 Apr 27, 2023	SELL	$145.48 - $175.02 $16,730 - $20,127	-115 Reduced 0.61%	18,875 $3.14 Billion
Q4 2022 Feb 16, 2023	BUY	$131.14 - $157.47 $179,137 - $215,104	1,366 Added 7.75%	18,990 $2.78 Billion
Q3 2022 Feb 16, 2023	BUY	$148.29 - $182.55 $75,479 - $92,917	509 Added 2.97%	17,624 $2.61 Billion
Q2 2022 Feb 16, 2023	BUY	$155.97 - $200.09 $228,184 - $292,731	1,463 Added 9.35%	17,115 $2.94 Billion
Q1 2022 Feb 16, 2023	BUY	$181.39 - $234.03 $202,612 - $261,411	1,117 Added 7.68%	15,652 $2.95 Billion
Q4 2021 Feb 16, 2023	BUY	$193.69 - $247.03 $2.82 Million - $3.59 Million	14,535 New	14,535 $3.55 Billion

Others Institutions Holding ZTS

# of Institutions

1,957

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $77.5B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bensler, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bensler, LLC with notifications on news.

Account